Haffkine Bio-Pharmaceutical Corporation Ltd.
Haffkine Bio-Pharmaceutical Corporation Ltd., commonly referred to as Haffkine, is a prominent player in the biopharmaceutical industry, headquartered in Mumbai, India. Established in 1899, the company has a rich history of innovation and excellence, particularly in the fields of vaccine production and biopharmaceuticals. Haffkine is renowned for its core products, which include vaccines for various infectious diseases, as well as a range of diagnostic kits and therapeutic solutions. The company’s commitment to quality and affordability sets it apart in a competitive market. With a strong presence across India and significant operational reach in international markets, Haffkine has achieved notable milestones, including recognition for its contributions to public health. As a trusted name in the biopharmaceutical sector, Haffkine continues to play a vital role in advancing healthcare solutions.
DitchCarbon Score
How does Haffkine Bio-Pharmaceutical Corporation Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Haffkine Bio-Pharmaceutical Corporation Ltd.'s score of 14 is lower than 99% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Haffkine Bio-Pharmaceutical Corporation Ltd.'s reported carbon emissions
Haffkine Bio-Pharmaceutical Corporation Ltd., headquartered in India, currently does not have available carbon emissions data for recent years. As a result, specific figures regarding their carbon footprint, including Scope 1, 2, or 3 emissions, are not provided. Additionally, there are no documented reduction targets or climate pledges outlined by the company. This absence of data suggests that Haffkine may still be in the early stages of formalising its climate commitments or reporting its emissions. In the context of the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to adopt science-based targets to mitigate their environmental impact. Haffkine's future initiatives in this area will be crucial for aligning with industry standards and addressing climate change effectively.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Haffkine Bio-Pharmaceutical Corporation Ltd. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
